{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:27:13Z","timestamp":1793809633861,"version":"4.6.1"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:p>This article discusses research providing renewed reasons to revisit the utility of glutamatergic drugs for treating schizophrenia.<\/jats:p>","DOI":"10.1001\/jamapsychiatry.2026.2862","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:30:49Z","timestamp":1790782249000},"page":"1187","source":"Crossref","is-referenced-by-count":0,"title":["Updating Treatment Goals for Schizophrenia"],"prefix":"10.1001","volume":"83","author":[{"given":"Bita","family":"Moghaddam","sequence":"first","affiliation":[{"name":"Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5381","key":"ynp260001r1","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"issue":"4","key":"ynp260001r2","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1152\/jn.00875.2004","article-title":"Activation of metabotropic glutamate 2\/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats.","volume":"93","author":"Homayoun","year":"2005","journal-title":"J Neurophysiol"},{"issue":"1","key":"ynp260001r3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00213-004-1982-8","article-title":"Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.","volume":"179","author":"Krystal","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"ynp260001r4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial.","volume":"13","author":"Patil","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"ynp260001r5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1001\/jamapsychiatry.2025.4091","article-title":"Glutamate levels in medial prefrontal cortex according to illness phase of never-medicated individuals with psychosis.","volume":"83","author":"Rivera-Ch\u00e1vez","year":"2026","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"ynp260001r6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuron.2013.02.011","article-title":"Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.","volume":"78","author":"Schobel","year":"2013","journal-title":"Neuron"},{"issue":"7906","key":"ynp260001r7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","article-title":"Mapping genomic loci implicates genes and synaptic biology in schizophrenia.","volume":"604","author":"Trubetskoy","year":"2022","journal-title":"Nature"},{"issue":"1","key":"ynp260001r8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41380-025-03279-4","article-title":"GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.","volume":"31","author":"Lemke","year":"2026","journal-title":"Mol Psychiatry"},{"issue":"9","key":"ynp260001r9","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1038\/s41380-026-03632-1","article-title":"Grin2a knockout in adolescent dopamine neurons disrupts prediction error signaling and produces a phenotype relevant to schizophrenia.","volume":"31","author":"Kielhold","year":"2026","journal-title":"Mol Psychiatry"},{"issue":"11","key":"ynp260001r10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2015.03.016","article-title":"Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2\/3 receptor agonist pomaglumetad methionil in schizophrenia.","volume":"78","author":"Kinon","year":"2015","journal-title":"Biol Psychiatry"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2854489\/jamapsychiatry_moghaddam_2026_np_260001_1793210341.01797.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:00:23Z","timestamp":1793808023000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2854489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.2862","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11,1]]}}}